Catalyst Wire Dossier Catalyst Wire Dossier

Fimasartan/Rosuvastatin fixed-dose combination tablet

fimasartan/rosuvastatin · Boryung Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fimasartan/Rosuvastatin fixed-dose combination tablet, covering 2014-10-15 to 2014-10-15. Get the full timeline:

Most recent: Clinical Trial Update: to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin [Phase 1]

See pricing